Pyrazinamide
Who holds supplier records for Pyrazinamide? 5 organisations hold a current record for Pyrazinamide: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 3 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (4) and Canada (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Pyrazinamide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/pyrazinamide
Reading the evidence
- 5 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
4 of the 5 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (5)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Pyrazinamide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Calyx Chemicals & Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 15553 · latest filing Jul 2001
- Macleods Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 30448 · latest filing May 2016
- DELMAR CHEMICALS INCCanadaActive DMF 15325 · latest filing Feb 2001
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 34229 · latest filing Nov 2019
- IndiaCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (3)
Certificates of Suitability on the EDQM register for Pyrazinamide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 6 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ANUH PHARMA LIMITED Mumbai | IN | CEP 2005-059 - Rev 04 Pyrazinamide | Feb 2026 | — |
| CALYX CHEMICALS AND PHARMACEUTICALS LIMITED Mumbai | IN | CEP 2000-036 - Rev 06 Pyrazinamide | May 2025 | — |
| MACLEODS PHARMACEUTICALS LIMITED Mumbai | IN | R1-CEP 2016-138 - Rev 01 Pyrazinamide | Mar 2023 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (3)
Organisations whose Type II DMFs for Pyrazinamide are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- SANOFI AVENTIS SPAInactive DMF 14623 · filed Dec 1999
- NORISTON LTDInactive DMF 8604 · filed Jun 1990
- BRACCO IND CHIMICA SPAInactive DMF 5909 · filed Jun 1985
Overview
Pyrazinamide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL614).
Chemical identity
- IUPAC name
- pyrazine-2-carboxamide
- Canonical SMILES
- C1=CN=C(C=N1)C(=O)N
- InChIKey
- IPEHBUMCGVEMRF-UHFFFAOYSA-N
- Synonyms
- Aldinamid, Aldinamide, .alpha.-pyrazinamide, D-50, Eprazin, Farmizina, Isopas, MK-56, Novamid, NSC-14911, Pirazimida, Pirazinamid
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Antimycobacterial
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Pyrazinamide?
5 organisations hold an active US FDA Type II Drug Master File or a CEP for Pyrazinamide: Calyx Chemicals & Pharmaceuticals Ltd. (India), Macleods Pharmaceuticals Ltd. (India), DELMAR CHEMICALS INC (Canada), MATRIX PHARMACORP PRIVATE LTD (India) and Anuh Pharma Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Pyrazinamide Drug Master Files are active?
Calyx Chemicals & Pharmaceuticals Ltd. (DMF 15553), Macleods Pharmaceuticals Ltd. (DMF 30448), DELMAR CHEMICALS INC (DMF 15325) and MATRIX PHARMACORP PRIVATE LTD (DMF 34229). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Pyrazinamide records mean?
3 organisations have only inactive Type II DMFs for Pyrazinamide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Pyrazinamide have a European Certificate of Suitability?
Yes. 3 organisations hold a valid CEP for Pyrazinamide on the EDQM register, including ANUH PHARMA LIMITED Mumbai (IN), CALYX CHEMICALS AND PHARMACEUTICALS LIMITED Mumbai (IN) and MACLEODS PHARMACEUTICALS LIMITED Mumbai (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Pyrazinamide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Pyrazinamide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.